BiomX, Inc. Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details) - Schedule of Outstanding Warrants to Purchase Common Stock Issued To Stockholders

Stockholders Equity (Details) - Schedule of Outstanding Warrants to Purchase Common Stock Issued To Stockholders	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Schedule of Outstanding Warrants to Purchase Common Stock Issued To Stockholders [Line Items]
Number of Shares of Common Stock Underlying Warrants	23,823,215
Private Placement Warrants [Member]
Schedule of Outstanding Warrants to Purchase Common Stock Issued To Stockholders [Line Items]
Issuance Date	IPO (December 13, 2018)
Expiration Date	Dec. 13, 2023
Exercise Price Per Share \| $ / shares	$ 11.5
Number of Shares of Common Stock Underlying Warrants	2,900,000
Public Warrants [Member]
Schedule of Outstanding Warrants to Purchase Common Stock Issued To Stockholders [Line Items]
Issuance Date	IPO (December 13, 2018)
Expiration Date	Oct. 28, 2024
Exercise Price Per Share \| $ / shares	$ 11.5
Number of Shares of Common Stock Underlying Warrants	3,500,000
2021 Registered Direct Offering Warrants [Member]
Schedule of Outstanding Warrants to Purchase Common Stock Issued To Stockholders [Line Items]
Issuance Date	SPA (July 28, 2021)
Expiration Date	Jan. 28, 2027
Exercise Price Per Share \| $ / shares	$ 5
Number of Shares of Common Stock Underlying Warrants	2,812,501
Pre-Funded Warrants [Member]
Schedule of Outstanding Warrants to Purchase Common Stock Issued To Stockholders [Line Items]
Issuance Date	February 27, 2023
Exercise Price Per Share \| $ / shares	$ 0.001
Number of Shares of Common Stock Underlying Warrants	2,776,428
Pre funded Warrants One [Member]
Schedule of Outstanding Warrants to Purchase Common Stock Issued To Stockholders [Line Items]
Issuance Date	May 4, 2023
Exercise Price Per Share \| $ / shares	$ 0.001
Number of Shares of Common Stock Underlying Warrants	11,834,286